Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Ivna Svoboda-Beusan

21846

Ivna

Svoboda-Beusan

dr. sc.

Naziv Uloga Akcije
Rezistencija na lijekove voditelj
Naziv Akcije
Savić Mlakar, Ana ULOGA PROUPALNIH I PROTUUPALNIH MEHANIZAMA U RAZVOJU REZISTENCIJE POSREDOVANE ABC TRANSPORTERIMA U UPALNIM BOLESTIMA CRIJEVA / Svoboda-Beusan, Ivna ; Bendelja, Krešo (mentor); Zagreb, Prirodoslovno-matematički fakultet, Zagreb, . 2015
Savić, Ana ; Babić, Žarko ; Troskot, Branko ; Bendelja, Krešo ; Svoboda-Beusan, Ivna Interplay of cytokines and SOCS molecules influence ABC transporter expression in ulcerative colitis // 2nd Meeting of middle-European Societies for Immunology and Allergology, Abstract Book. 2013. str. 79-79
Savić, Ana ; Troskot, Branko ; Babić, Žarko ; Bendelja, Krešo ; Svoboda-Beusan, Ivna Multidrug resistance in inflammatory bowel disease. Pgp and MRP1 expression pattern comparison in the lining of gastrointestinal tract // 2011 Annual Meeting of the Croatian Immunological Society, Book of Abstracts. 2011. str. 20-20
Savić, Ana ; Troskot, Branko ; Babić, Žarko ; Bendelja, Krešo ; Svoboda-Beusan, Ivna Multidrug resistance in inflammatory bowel disease. Localization and expression profiles of ABC transporters Pgp and MRP1 in gastrointestinal tract // 3. South East European EFIS-EJI Immunology School (SEEIS2011). 2011. str. 16-16
Savić, Ana ; Troskot, Branko ; Babić, Žarko ; Bendelja, Krešo ; Svoboda-Beusan, Ivna Multidrug resistance in inflammatory bowel disease. Expression profiles of MDR1 and MRP1 along gastrointestinal tract // FEBS 16th International Summer School on Immunology, Immune system: Genes, receptors and regulation, Abstract book. 2011. str. 110-110
Savić, Ana ; Ajduković, Radmila ; Marušić-Vrsalović, Maruška ; Livun, Ana ; Bendelja, Krešo ; Svoboda-Beusan, Ivna Low levels of residual disease in CML are associated with low molecular level of oncogene BCR-ABL chimeric genes and low Pgp activity // Hrvatsko društvo za istraživanje raka (HDIR), Croatian Association for Cancer Research Book of abstracts). HDIR-1 From Bench to Clinic. First meeting with international participation / Maja Sabol and Sonja Levanat (ur.). Zagreb: Hrvatsko društvo za istraživanje raka (HDIR), 2010. str. 41-41
Savić, Ana ; Ajduković, Radmila ; Marušić-Vrsalović, Maruška ; Livun, Ana ; Bendelja, Krešo ; Svoboda-Beusan, Ivna Low levels of residual disease in CML are associated with low molecular level of oncogene BCR-ABL chimeric genes and low Pgp activity // Annual Meeting of the Austrian Sociezy for Allergology and Immunology (ÖGAI) in co-operation with the national Societies of Croatia, Czech Republic, Hungary, Slovakia and Slovenia. Beč: ÖGAI, Österreichische Gesellschaft für Allergologie und Immunologie, 2010. str. 45-45
Babić, Žarko ; Kučišec-Tepeš, Nastja ; Troskot, Rosana ; Dorosulić, Zdravko ; Svoboda-Beusan, Ivna ; The Importance of P-glycoproteim Multidrug Transporter Activity Measurement in Patients with Helicobacter Pyroli Infection // Collegium antropologicum, 33 (2009), 4; 1145-1150
Savić, Ana ; Ajduković, Radmila ; Marušić Vrsalović, Maruška ; Livun, Ana ; Bendelja, Krešo ; Svoboda Beusan, Ivna Longterm follow-up of Pgp activity and molecular response in CML patients treated with imatinib mesylate // 2009 Annual Meeting of the Croatian Immunological Society, Book of Abstracts. Zagreb, 2009. str. 44-44
Gotovac, Katja ; Bendelja, Krešo ; Vdović, Valerija ; Lupret-Goleš, Lea ; Vidović, Anđelko ; Fabijanić, Ines ; Cepika, Alma Martina ; Svoboda-Beusan, Ivna ; Ljevaković, Đurđica ; Šporec, Vesna et al. Alternative to animal testing: new approaches in the development and control of biologicals // Alternatives to animal testing: new approaches in the development and control of biologicals. Conference Document / European Directorate for the Quality of Medicines & Health Care (EDQM), / Council of Europe (ur.). European Directorate for the Quality of Medicines & Health Care (EDQM),, 2008. str. 189-190
nije evidentirano
nije evidentirano